Shaldam, M.; Nocentini, A.; Elsayed, Z.M.; Ibrahim, T.M.; Salem, R.; El-Domany, R.A.; Capasso, C.; Supuran, C.T.; Eldehna, W.M.
Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors. Int. J. Mol. Sci. 2021, 22, 11119.
https://doi.org/10.3390/ijms222011119
AMA Style
Shaldam M, Nocentini A, Elsayed ZM, Ibrahim TM, Salem R, El-Domany RA, Capasso C, Supuran CT, Eldehna WM.
Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors. International Journal of Molecular Sciences. 2021; 22(20):11119.
https://doi.org/10.3390/ijms222011119
Chicago/Turabian Style
Shaldam, Moataz, Alessio Nocentini, Zainab M. Elsayed, Tamer M. Ibrahim, Rofaida Salem, Ramadan A. El-Domany, Clemente Capasso, Claudiu T. Supuran, and Wagdy M. Eldehna.
2021. "Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors" International Journal of Molecular Sciences 22, no. 20: 11119.
https://doi.org/10.3390/ijms222011119
APA Style
Shaldam, M., Nocentini, A., Elsayed, Z. M., Ibrahim, T. M., Salem, R., El-Domany, R. A., Capasso, C., Supuran, C. T., & Eldehna, W. M.
(2021). Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors. International Journal of Molecular Sciences, 22(20), 11119.
https://doi.org/10.3390/ijms222011119